投稿者: idec_admin List of articles

2024.10.08

Key Regulatory Review Systems for Pharmaceuticals in Japan

Key Regulatory Review Systems for Pharmaceuticals in Japan Overview: Japan’s Ministry of Health, Labour, and W […]

2024.09.25

MHLW FY2025 Budget Proposal for the Establishment of Infrastructure to Implement the FIH (First-In-Human) Trial for Global Development

MHLW FY2025 Budget Proposal for the Establishment of Infrastructure to Implement the FIH (First-In-Human) Tria […]

2024.09.11

Japan’s 2025 Budget Proposal to Tackle Drug Lag and Orphan Drug Development

Japan’s 2025 Budget Proposal to Tackle Drug Lag and Orphan Drug Development Introduction to Japan’s Regulatory […]

2024.08.06

Japan Revises Regulations on Post-Marketing Surveillance

Japan Revises Regulations on Post-Marketing Surveillance Introduction to Regulatory Changes  According to […]

2024.07.18

New Consultation Center for Pediatric and Rare Disease Drugs Launched in Japan

New Consultation Center for Pediatric and Rare Disease Drugs Launched in Japan Introduction to the New Regulat […]

2024.06.26

Record-Breaking Growth in Japan’s Pharmaceutical Market for FY2023

Record-Breaking Growth in Japan’s Pharmaceutical Market for FY2023 Introduction to Market Growth According to […]

2024.06.04

Increased Frequency of Drug Price Listing Reviews in Japan

Increased Frequency of Drug Price Listing Reviews in Japan Introduction to Regulatory Changes According to the […]

2024.05.20

ALS Clinical Development Guideline in Japan

ALS Clinical Development Guideline in Japan Introduction According to the news (ALS薬、国内初の治験GL策定へ  和泉研究班、最新手法で開 […]

2024.05.01

Updates to Pediatric Drug Development Guidelines in Japan

Updates to Pediatric Drug Development Guidelines in Japan According to the news (小児用薬の計画策定推奨で通知  4月1日から適用、厚労省医 […]

2024.04.23

Strategic Insights for Global Pharma: Drug Development in Japan 

Strategic Insights for Global Pharma: Drug Development in Japan  According to the article (Diff […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
Phone:+81-3-6304-5570